Jun 23, 2025

Mechanism of Action: Absorbable Hemostatic Powder

Leave a message

Quick Summary: 3 Core Actions of Hemostatic Powder

Mechanism Effect Onset Time
Physical scaffold Platelet adhesion & aggregation Immediate (0–15 sec)
Coagulation cascade activation Thrombin burst & fibrin formation 15–60 sec
Biodegradation Complete absorption without residue 7–14 days

Key takeaway: Absorbable hemostatic powder accelerates natural hemostasis and reduces bleeding time to typically 1 minute in surgical applications.

 

1. Product Overview: Surgiclean® MPH Absorbable Hemostatic Particles

Surgiclean® MPH is an absorbable hemostatic powder indicated in surgical procedures as an adjunctive hemostatic device to assist when control of capillary, venous, and arteriolar bleeding by pressure, ligature, and other conventional procedures is ineffective or impractical.

Key Specifications:

Source: Plant starch (potato)

Technology: Reverse phase emulsification cross-linking technology

Particle size: 30.8–97 μm (spatial net microstructure)

Sterilization: EO sterilization

Available sizes: 0.5g, 1.0g, 2.0g, 3.0g, 5.0g per piece

The microporous structure provides a porosity that enables rapid blood absorption-comparable starch-based hemostats have demonstrated water absorption rates exceeding 1,200% .

 

2. Normal Hemostasis vs. Powder-Enhanced Hemostasis

Phase Normal Hemostasis With Absorbable Hemostatic Powder
Fibrin clot strength Baseline 2–3× stronger than physiological clot
Time to complete hemostasis 4–8 min Typically 1 minute

The powder does not replace the body's clotting system-it amplifies it by providing a highly reactive surface and localized pro-coagulant signals.

hemostatic-powder

 

3. Mechanism of Absorbable Hemostatic Powder

3.1 Dual Action Mechanism

With hydrophilic molecular sieve, the hemostatic agent powder​ can absorb water in the blood instantly, and gather the formed components in the blood on the surface of the particles to produce "gelled matrix" and form a mechanical barrier to stop bleeding.  At the same time, local concentrations of platelets, coagulation factors, and fibrin are greatly increased to initiate and strengthen endogenous coagulation mechanism. The dual mechanism co-formed clot block to stop bleeding.

 

3.2 Biodegradation & Absorption Kinetics

Unlike non-absorbable agents, Surgiclean® MPH is designed for complete clearance:

Final degradation products: Water and carbon dioxide

Complete absorption: Within 14 days

Safety profile: Over 810,000 pieces used with no reported adverse events

Independent studies on starch-based hemostatic powders have demonstrated that degradation and absorption is essentially completed after 42 days of implantation in the body, with no abnormalities observed in general signs, blood coagulation indicators, or pathological examination . Another study showed that calcium-enriched porous starch hemostats were almost completely absorbed by liver tissue after 14 days .

No secondary surgery is required for removal-ideal for internal surgical use.

 

4. Comparative Analysis: Hemostatic Powder vs. Other Agents

Agent Mechanism Absorption Best for Limitation
Surgiclean® MPH Physical + cascade activation Yes (7–14 days) Oozing surfaces, irregular wounds Not for high-pressure arterial bleed
Non-absorbable hemostatic gauze Physical + sometimes chitosan No Packing cavities Requires removal
Gelatin sponge + thrombin Physical scaffold + enzymatic Yes (4–8 weeks) Larger surface areas Slower activation, requires mixing
Fibrin glue Enzymatic coagulation Yes (1–2 weeks) Sealing anastomoses Expensive, requires preparation

Clinical recommendation: Use powder for diffuse parenchymal oozing (liver, spleen, thyroid) or bone surfaces-areas where gauze or sponges cannot conform.

 

5. Clinical Evidence & Safety Data

5.1 Safety Profile

Parameter Data
Clinical usage Over 810,000 pieces used
Adverse events None reported
Composition 100% plant-based, thrombin-free, non-pyrogenic
Biocompatibility Excellent, no allergic reactions, no toxic side effects

 

5.2 Application Success Factors

According to clinical experience, the most common reasons for hemostasis failure include:

Hemostatic powder does not touch the bleeding point

Dry gauze is not pressed or pressing time is too short

Insufficient dosage

Solution: Only need to rinse the wound surface with normal saline, remove accumulated blood, and re-apply to achieve satisfactory hemostatic effect.

 

6. Clinical Applications by Surgical Specialty

Cardiovascular and Thoracic Surgery

Cardiovascular surgery: Aneurysm (around vascular anastomosis and tumor bed), coronary artery bypass grafting

Lung cancer surgery: Lung stump (stop bleeding, reduce lung leaks), lymph node dissection wounds

Esophageal cancer surgery: Esophageal bed, freeing stomach wound, lymph node dissection

Mediastinal tumor: Mediastinal bed, sternum split

General and Hepatobiliary Surgery

Hepatobiliary surgery: Hepatic lobectomy, biliary surgery, liver transplantation

Portal hypertension: Devascularization and shunting (spleen laceration, perivascular anastomosis)

Pancreas and spleen surgery: Splenectomy (spleen fossa and pedicle), pancreatic surgery

Gastrointestinal surgery: Gastric cancer (lymph node dissection), rectal cancer surgery

Thyroid and breast surgery: Thyroid parenchyma, axilla and chest wall

Orthopedic Surgery

Spine surgery: Cervical, thoracic, and lumbar spine (Note: Not for use in spinal canal)

Joint surgery: Hip replacement, knee replacement

Limb trauma: Upper and lower extremity fractures

Bone tumor: Extremities and spinal tumors

Minimally Invasive Surgery

Thyroid, splenectomy, gallbladder, adnexal tumors, and others

Contraindication: Surgiclean® MPH cannot be used in neurological or ophthalmic surgery.

 

7. Method of Usage

Prepare: Remove excess blood using aseptic sponge or gauze to expose the bleeding site

Apply: Apply Surgiclean® powder immediately, fully covering the wound area

Press: Press on the wound with a dry gauze for 2–3 minutes

Check: Irrigate excess powder once bleeding has stopped; if bleeding continues, repeat the above methods

Key Points:

Clotting process begins on contact regardless of patient's coagulation status

Complete hemostasis achieved within minutes (normally 1 minute)

Can be used repeatedly for the same wound

No mixing, no refrigeration-ready on demand

 

8. References

Peer-Reviewed Literature

Evaluation of the hemostatic efficacy and safety of an absorbable hemostatic powder based on a porcine intracranial hemorrhage model. PubMed, 2026. View on PubMed

Ardehali A, Spotnitz WD, et al. Evaluation of the safety and efficacy of a new hemostatic powder using a quantitative surface bleeding severity scale. Journal of Cardiac Surgery, 2019;34(1):50-62. View on PubMed

Evaluation of hemostatic powder vs. absorbable gelatin sponge and thrombin. Medline Abstract, 2019. View on Medscape

Bioabsorbable Carboxymethyl Starch–Calcium Ionic Assembly Powder as a Hemostatic Agent. PMC, 2022. View on PMC

Clinical comparison between microporous polysaccharide hemispheres (MPH) and fibrin glue in laparoscopic partial nephrectomy. PubMed, 2012. View on PubMed

Zhu J, et al. Hemostatic Efficacy and Biocompatibility Evaluation of a Novel Absorbable Porous Starch Hemostat. Surgical Innovation, 2022. View on PubMed

PERCLOT Absorbable Hemostatic Powder – Mechanism of Action. Baxter Advanced Surgery. View on Baxter

Send Inquiry